
    
      This study will examine the potential of a novel formulation of hemp-derived CBD (CHI-554) to
      reduce fear elicited via a safe, well-established, controlled, laboratory-based carbon
      dioxide (CO2)-enriched air biological challenge that causes abrupt increases in bodily
      arousal.
    
  